Astria Therapeutics (NASDAQ:ATXS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Astria Therapeutics (ATXS) operate in?

Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Astria Therapeutics Stock (NASDAQ: ATXS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	121.00 / 315.39K
Day Range	- - -
52 Wk Range	4.41 - 16.90
Market Cap	$542.33M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	6.51%
Days to Cover	17.92

Recent News

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.

Avi Kapoor

$5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Avi Kapoor

Exxon Mobil To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	121.00 / 315.39K
Day Range	- - -
52 Wk Range	4.41 - 16.90
Market Cap	$542.33M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	6.51%
Days to Cover	17.92

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Astria Therapeutics (ATXS) stock?

You can purchase shares of Astria Therapeutics (NASDAQ:ATXS) through any online brokerage.

View our list of the best stock brokerages

Who are Astria Therapeutics (ATXS) competitors?

Other companies in Astria Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).

What is the forecast, or price target, for Astria Therapeutics (ATXS) stock?

Astria Therapeutics has a consensus price target of $24.33.

What is the current price for Astria Therapeutics (ATXS)?

The stock price for Astria Therapeutics (NASDAQ: ATXS) is $9.61 last updated November 22, 2024 at 7:00 AM EST.

Does Astria Therapeutics (ATXS) pay a dividend?

There are no upcoming dividends for Astria Therapeutics.

When is Astria Therapeutics (NASDAQ:ATXS) reporting earnings?

Astria Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Astria Therapeutics (ATXS) going to split?

There is no upcoming split for Astria Therapeutics.

What sector and industry does Astria Therapeutics (ATXS) operate in?

Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Astria Therapeutics

Astria Therapeutics (ATXS) Forecast